- Investing Ideas
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
39
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
39 companies
AstraZeneca
Market Cap: UK£193.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£122.34
7D
1.5%
1Y
3.0%
Bonesupport Holding
Market Cap: SEK 14.8b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 228.20
7D
0.9%
1Y
-22.6%
Diaceutics
Market Cap: UK£121.8m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.48
7D
3.1%
1Y
7.3%
Vitrolife
Market Cap: SEK 12.9b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 95.05
7D
6.0%
1Y
-29.2%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €204.2m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.72
7D
1.9%
1Y
0.2%
Hyphens Pharma International
Market Cap: S$112.8m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.36
7D
-1.4%
1Y
10.6%
Xeris Biopharma Holdings
Market Cap: US$1.6b
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$8.74
7D
-1.2%
1Y
9.9%
Renata
Market Cap: ৳53.1b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.
RENATA
৳462.80
7D
-0.9%
1Y
-2.5%
Almirall
Market Cap: €2.3b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
ALM
€10.50
7D
1.2%
1Y
-5.9%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.1b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€60.80
7D
1.8%
1Y
5.7%
Natera
Market Cap: US$47.2b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$336.71
7D
8.0%
1Y
103.2%
Frontage Holdings
Market Cap: HK$2.4b
Provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.21
7D
-4.7%
1Y
-12.7%
Telix Pharmaceuticals
Market Cap: AU$5.3b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$15.49
7D
-8.0%
1Y
-15.8%
Pangaea Oncology
Market Cap: €55.7m
A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.
PANG
€1.55
7D
0%
1Y
-9.9%
Mesoblast
Market Cap: AU$3.1b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.36
7D
-0.4%
1Y
-5.2%
Aroa Biosurgery
Market Cap: AU$193.7m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.56
7D
-3.4%
1Y
-11.8%
Galderma Group
Market Cap: CHF 40.0b
Operates as a dermatology company worldwide.
GALD
CHF 171.00
7D
0.03%
1Y
22.0%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.8b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€52.65
7D
-0.8%
1Y
-0.7%
Emergent BioSolutions
Market Cap: US$265.6m
A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally.
EBS
US$5.64
7D
21.0%
1Y
-35.2%
AbbVie
Market Cap: US$467.4b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$265.79
7D
2.7%
1Y
27.6%
Teva Pharmaceutical Industries
Market Cap: US$43.0b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$38.10
7D
4.2%
1Y
109.9%
Chugai Pharmaceutical
Market Cap: JP¥11.6t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,051.00
7D
2.4%
1Y
10.5%
InSilico Medicine Cayman TopCo
Market Cap: HK$26.9b
Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.
3696
HK$47.00
7D
19.2%
1Y
n/a
hVIVO
Market Cap: UK£44.7m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.064
7D
-3.0%
1Y
-36.0%
Sotera Health
Market Cap: US$5.5b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$19.51
7D
5.4%
1Y
19.0%
Akeso
Market Cap: HK$86.8b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$94.20
7D
5.5%
1Y
-40.0%
Innovent Biologics
Market Cap: HK$191.2b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$109.80
7D
11.8%
1Y
20.7%
Ligand Pharmaceuticals
Market Cap: US$5.6b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$281.72
7D
-2.0%
1Y
76.3%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$53.9b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$62.00
7D
2.6%
1Y
192.2%
Merck
Market Cap: US$371.7b
Operates as a healthcare company worldwide.
MRK
US$156.45
7D
15.7%
1Y
84.1%
BioGaia
Market Cap: SEK 11.8b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.50
7D
0.4%
1Y
10.5%
Selvita
Market Cap: zł525.0m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł27.45
7D
-3.3%
1Y
-12.0%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥26.9b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥57.79
7D
-2.1%
1Y
-23.7%
Strides Pharma Science
Market Cap: ₹90.6b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹982.90
7D
2.7%
1Y
14.3%
Viyash Scientific
Market Cap: ₹114.9b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹263.25
7D
-3.2%
1Y
51.3%
WuXi XDC Cayman
Market Cap: HK$97.8b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$77.25
7D
13.5%
1Y
41.6%